3-O-(4-Methoxy)cinnamoyl caudatin

ID: ALA2046559

Chembl Id: CHEMBL2046559

PubChem CID: 66573231

Max Phase: Preclinical

Molecular Formula: C38H50O9

Molecular Weight: 650.81

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C/C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@]4(O)[C@@H]3C[C@@H](OC(=O)/C=C(\C)C(C)C)[C@@]3(C)[C@]4(O)CC[C@@]3(O)C(C)=O)C2)cc1

Standard InChI:  InChI=1S/C38H50O9/c1-23(2)24(3)20-33(41)47-31-22-30-34(5)16-15-29(46-32(40)13-10-26-8-11-28(45-7)12-9-26)21-27(34)14-17-37(30,43)38(44)19-18-36(42,25(4)39)35(31,38)6/h8-14,20,23,29-31,42-44H,15-19,21-22H2,1-7H3/b13-10+,24-20+/t29-,30+,31+,34-,35+,36+,37-,38+/m0/s1

Standard InChI Key:  SEXRIOKVROQFNA-GAKBQJCISA-N

Associated Targets(Human)

TLR4 Tchem Toll-like receptor 4 (970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AD293 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR3 Tbio Toll-like receptor 3 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR2 Tchem Toll-like receptor 2 (975 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFKBIA Tchem NF-kappaB inhibitor alpha (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFKB2 Tchem Nuclear factor NF-kappa-B p100/p49 subunits (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 650.81Molecular Weight (Monoisotopic): 650.3455AlogP: 5.26#Rotatable Bonds: 8
Polar Surface Area: 139.59Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.39CX Basic pKa: CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 1Heavy Atoms: 47QED Weighted: 0.20Np Likeness Score: 2.31

References

1. Wang LJ, Geng CA, Ma YB, Luo J, Huang XY, Chen H, Zhou NJ, Zhang XM, Chen JJ..  (2012)  Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents.,  54  [PMID:22687441] [10.1016/j.ejmech.2012.05.012]
2. Huang LJ, Chen SR, Yuan CM, Gu W, Guo BJ, Wang YT, Wang Y, Hao XJ..  (2017)  C21-steroidal pregnane sapogenins and their derivatives as anti-inflammatory agents.,  25  (13): [PMID:28506585] [10.1016/j.bmc.2017.04.045]

Source